期刊文献+

慢性乙型肝炎患者外周血树突状细胞免疫功能的研究 被引量:2

Study on the immune function of peripheral blood dendritic cells from chronic B patients
下载PDF
导出
摘要 目的 研究慢性乙型肝炎患者外周血树突状细胞 (DC)表面分子HLA -DR、CD1a、CD80 、CD86表达水平及其与DC免疫功能的相关性。方法 临床确诊的慢性乙型肝炎轻度患者 1 0例 ,从其外周血中分离单个核细胞 ,体外培养扩增DC ,流式细胞仪检测DC表型HLA -DR、CD1a、CD80 、CD86。以健康成人 1 0例作为对照。结果 慢性乙型肝炎患者DC表面HLA -DR、CD1a、CD80 、CD86分别为 :48.63± 6.34,2 7.73±7.1 9,2 1 .0 5± 8.33,1 8.5 8± 5 .5 1 ,明显低于对照组 :83.1 1± 6.46,5 2 .80± 1 1 .70 ,36.1 1± 7.5 5 ,40 .83± 5 .48,两者相比差异显著 (P <0 .0 0 1 )。结论 慢性乙型肝炎患者外周血DC表面HLA -DR、CD1a、CD80 、CD86表达水平下降 。 Objective To study the property of dendritic cells(DCs) of peripheral blood monocytes (PBMC) in patients with chronic HBV infection and identify the relations with immune function.Methods Ten patients with persistent HBV infection were included in this study, ten healthy subjects being used as a control group. The peripheral blood mononuclear cells(PBMC) were incubated and induced into mature dendritic cells in the RPMI-1640 medium in the presence of cytokines GM-CSF,IL-4 and TNF-a for a total 12 days. Then using FCM to study the expression levels of HLA-DR,CD 1a ,CD 80 and CD 86 .Results The expression levels of HLA-DR,CD 1a ,CD 80 and CD 86 on DC surface from patients were significantly lower than that from healthy individuals (48.63±6.34 vs 83.11±6.46 for HLA-DR,27.73±7.19 vs 52.80±11.70 for CD 1a ,21.05±8.33 vs 36.11±7.55 for CD 80 ,18.58±5.51 vs 40.83±5.48 for CD 86 ), P <0.001.Conclusion The patients with chronic HBV infection have the defective function and immature phenotype of dendritic cells ,which may be associated with the inability of efficient presentation of HBV antigen to host immune system for the clearance of HBV.
作者 唐艳萍 邵沂
出处 《兰州医学院学报》 2002年第4期5-8,共4页 Journal of Lanzhou Medical College
关键词 慢性乙型肝炎 外周血 树突状细胞 免疫功能 Hepatitis B virus Dendritic cells Immune cellular
  • 相关文献

参考文献4

二级参考文献118

  • 1章卫平,曹雪涛,张明徽,黄欣,朱学军,叶天星.GM-CSF重组腺病毒扩增的骨髓树突状细胞体外经肿瘤抗原刺激后诱导抗肿瘤免疫应答[J].中国免疫学杂志,1997,13(1):29-33. 被引量:14
  • 2章卫平,曹雪涛,黄欣,王建莉,张明徽,叶天星.基因修饰的树突状细胞融合后的瘤苗抗肿瘤免疫应答的实验研究[J].中华医学杂志,1997,77(1):39-42. 被引量:30
  • 3[1] Kuniyoshi JS,Kuniyoshi CJ,Lim AM,et al.Dendritic cell secretion of IL-15 is induced by recombinant hu CD40LT and angments the stimulation of antigen-specific cytolytic T cells[J].Cell Immunol,1999,193(1):48-58.
  • 4[2] Salgaller ML,Tjoa BA,Lodge PA,et al.Dendritic cell-based immunotherapy of prostate cancer[J].Crit Rev Immunol,1998,18(1-2):109.
  • 5[3] Fallarino F,Uyttenhove C,Boon T,et al.Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12[J].Int J Cancer,1999,80(2):324-333.
  • 6[4] Shimizu K,Fields RC,Giedlin M,et al.Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines.[J].Proc Natl Acad Sci USA,1999,96(5):2268—2273.
  • 7[5] Eamonn Coueney,Grayson H.Wheatley,H.Kim.Lyerly,et al.Active immunization using dendritic cells mixed with tumor cells inhibits the growth of primary breast cancer[J].Surgery,1997,122(2):228—234.
  • 8[6] Christina M.Celluzzi,Louis D Falo.Cutting edge:physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection[J].J Immunol,1998,160(7):3081—3085.
  • 9[7] Amigorena S.Anti-tumour immunotherapy using dendritic-cell-derived exosomes[J]. Immunol Rev,1998,165:39—46.
  • 10[8] Zitvogel L,Regnault A,Lozier A,et al.Eradication of established murine tumors using a novel cell-free vaccine:dendritic-cell-derived exosomes[J].Nat-Med,1998,4(5):594—600.

共引文献8

同被引文献45

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部